Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)

Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0) Publisher Pubmed

Willasch AM¹ ; Peters C² ; Sedlacek P³ ; Dalle JH⁴ ; Kitraroussou V⁵ ; Yesilipek A⁶ ; Wachowiak J⁷ ; Lankester A⁸ ; Prete A⁹ ; Hamidieh AA¹⁰ ; Ifversen M¹¹ ; Buechner J¹² ; Krivan G¹³ ; Hamladji RM¹⁴ Show All Authors

Willasch AM¹
Peters C²
Sedlacek P³
Dalle JH⁴
Kitraroussou V⁵
Yesilipek A⁶
Wachowiak J⁷
Lankester A⁸
Prete A⁹
Hamidieh AA¹⁰
Ifversen M¹¹
Buechner J¹²
Krivan G¹³
Hamladji RM¹⁴
Diazdeheredia C¹⁵
Skorobogatova E¹⁶
Michel G¹⁷
Locatelli F^{18, 19}
Bertaina A^{18, 19, 20}
Veys P²¹
Dupont S²²
Or R²³
Gungor T²⁴
Aleinikova O²⁵
Sufliarska S²⁶
Sundin M²⁷
Rascon J²⁸
Kaare A²⁹
Nemet D³⁰
Fagioli F³¹
Klingebiel TE¹
Styczynski J³²
Bierings M³³
Nagy K³⁴
Abecasis M³⁵
Afanasyev B³⁶
Ansari M³⁷
Vettenranta K³⁸
Alseraihy A³⁹
Chybicka A⁴⁰
Robinson S⁴¹
Bertrand Y⁴²
Kupesiz A⁴³
Ghavamzadeh A⁴⁴
Campos A⁴⁵
Pichler H²
Dalissier A⁴⁶
Labopin M⁴⁷
Corbacioglu S⁴⁸
Balduzzi A⁴⁹
Galimard JE⁴⁶
Bader P¹

Source: Bone Marrow Transplantation Published:2021

Abstract

The article “Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study,” written by Andre Manfred Willasch, Christina Peters, Petr Sedlacek, Jean-Hugues Dalle, Vassiliki Kitra-Roussou, Akif Yesilipek, Jacek Wachowiak, Arjan Lankester, Arcangelo Prete, Amir Ali Hamidieh, Marianne Ifversen, Jochen Buechner, Gergely Krivan, Rose-Marie Hamladji, Cristina Diaz-de-Heredia, Elena Skorobogatova, Gerard Michel, Franco Locatelli, Alice Bertaina, Paul Veys, Sophie Dupont, Reuven Or, Tayfun Gungor, Olga Aleinikova, Sabina Sufliarska, Mikael Sundin, Jelena Rascon, Ain Kaare, Damir Nemet, Franca Fagioli, Thomas Erich Klingebiel, Jan Styczynski, Marc Bierings, Kalman Nagy, Manuel Abecasis, Boris Afanasyev, Marc Ansari, Kim Vettenranta, Amal Alseraihy, Alicja Chybicka, Stephen Robinson, Yves Bertrand, Alphan Kupesiz, Ardeshir Ghavamzadeh, Antonio Campos, Herbert Pichler, Arnaud Dalissier, Myriam Labopin, Selim Corbacioglu, Adriana Balduzzi, Jacques-Emmanuel Galimard, Peter Bader, on behalf of the EBMT Paediatric Diseases Working Party, was originally published online first without Open Access. After publication in volume 55, issue 8, page 1540–1551, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2020 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 InternationalS License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/ 4.0. Open access funding was enabled and organized by Projekt DEAL. © The Author(s) 2021

Related Docs

View other Related Docs

1. Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study, Bone Marrow Transplantation (2020)

2. Resistance to Single-Agent Chemotherapy in Low-Risk Gestational Trophoblastic Neoplasia, Caspian Journal of Internal Medicine (2023)

3. A Single-Center Experience With Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: A Modest Pitch for Non-Total Body Irradiation Conditioning Regimens, Experimental and Clinical Transplantation (2019)

Experts (# of related papers)

View all Related Experts

Maryam Behfar (7)

Amir Ali Hamidieh (7)

Style	Citing Format
MLA	Willasch AM, et al.. "Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)." Bone Marrow Transplantation, vol. 56, no. 10, 2021, pp. 2615-.
APA	Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Krivan G, Hamladji RM, Diazdeheredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, ... Bader P (2021). Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0). Bone Marrow Transplantation, 56(10), 2615-.
Chicago	Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, Wachowiak J, et al.. "Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)." Bone Marrow Transplantation 56, no. 10 (2021): 2615-.
Harvard	Willasch AM et al. (2021) 'Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)', Bone Marrow Transplantation, 56(10), pp. 2615-.
Vancouver	Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, et al.. Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0). Bone Marrow Transplantation. 2021;56(10):2615-.
BibTex	@article{ author = {Willasch AM and Peters C and Sedlacek P and Dalle JH and Kitraroussou V and Yesilipek A and Wachowiak J and Lankester A and Prete A and Hamidieh AA and Ifversen M and Buechner J and Krivan G and Hamladji RM and Diazdeheredia C and Skorobogatova E and Michel G and Locatelli F and Bertaina A and Veys P and Dupont S and Or R and Gungor T and Aleinikova O and Sufliarska S and Sundin M and Rascon J and Kaare A and Nemet D and Fagioli F and Klingebiel TE and Styczynski J and Bierings M and Nagy K and Abecasis M and Afanasyev B and Ansari M and Vettenranta K and Alseraihy A and Chybicka A and Robinson S and Bertrand Y and Kupesiz A and Ghavamzadeh A and Campos A and Pichler H and Dalissier A and Labopin M and Corbacioglu S and Balduzzi A and Galimard JE and Bader P}, title = {Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)}, journal = {Bone Marrow Transplantation}, volume = {56}, number = {10}, pages = {2615-}, year = {2021} }
RIS	TY - JOUR AU - Willasch AM AU - Peters C AU - Sedlacek P AU - Dalle JH AU - Kitraroussou V AU - Yesilipek A AU - Wachowiak J AU - Lankester A AU - Prete A AU - Hamidieh AA AU - Ifversen M AU - Buechner J AU - Krivan G AU - Hamladji RM AU - Diazdeheredia C AU - Skorobogatova E AU - Michel G AU - Locatelli F AU - Bertaina A AU - Veys P AU - Dupont S AU - Or R AU - Gungor T AU - Aleinikova O AU - Sufliarska S AU - Sundin M AU - Rascon J AU - Kaare A AU - Nemet D AU - Fagioli F AU - Klingebiel TE AU - Styczynski J AU - Bierings M AU - Nagy K AU - Abecasis M AU - Afanasyev B AU - Ansari M AU - Vettenranta K AU - Alseraihy A AU - Chybicka A AU - Robinson S AU - Bertrand Y AU - Kupesiz A AU - Ghavamzadeh A AU - Campos A AU - Pichler H AU - Dalissier A AU - Labopin M AU - Corbacioglu S AU - Balduzzi A AU - Galimard JE AU - Bader P TI - Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0) JO - Bone Marrow Transplantation VL - 56 IS - 10 SP - 2615 EP - PY - 2021 ER -

Style

Citing Format

MLA

Willasch AM, et al.. "Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)." Bone Marrow Transplantation, vol. 56, no. 10, 2021, pp. 2615-.

APA

Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Krivan G, Hamladji RM, Diazdeheredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, ... Bader P (2021). Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0). Bone Marrow Transplantation, 56(10), 2615-.

Chicago

Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, Wachowiak J, et al.. "Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)." Bone Marrow Transplantation 56, no. 10 (2021): 2615-.

Harvard

Willasch AM et al. (2021) 'Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)', Bone Marrow Transplantation, 56(10), pp. 2615-.

Vancouver

Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, et al.. Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0). Bone Marrow Transplantation. 2021;56(10):2615-.

BibTex

@article{ author = {Willasch AM and Peters C and Sedlacek P and Dalle JH and Kitraroussou V and Yesilipek A and Wachowiak J and Lankester A and Prete A and Hamidieh AA and Ifversen M and Buechner J and Krivan G and Hamladji RM and Diazdeheredia C and Skorobogatova E and Michel G and Locatelli F and Bertaina A and Veys P and Dupont S and Or R and Gungor T and Aleinikova O and Sufliarska S and Sundin M and Rascon J and Kaare A and Nemet D and Fagioli F and Klingebiel TE and Styczynski J and Bierings M and Nagy K and Abecasis M and Afanasyev B and Ansari M and Vettenranta K and Alseraihy A and Chybicka A and Robinson S and Bertrand Y and Kupesiz A and Ghavamzadeh A and Campos A and Pichler H and Dalissier A and Labopin M and Corbacioglu S and Balduzzi A and Galimard JE and Bader P}, title = {Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)}, journal = {Bone Marrow Transplantation}, volume = {56}, number = {10}, pages = {2615-}, year = {2021} }

RIS

TY - JOUR
AU - Willasch AM
AU - Peters C
AU - Sedlacek P
AU - Dalle JH
AU - Kitraroussou V
AU - Yesilipek A
AU - Wachowiak J
AU - Lankester A
AU - Prete A
AU - Hamidieh AA
AU - Ifversen M
AU - Buechner J
AU - Krivan G
AU - Hamladji RM
AU - Diazdeheredia C
AU - Skorobogatova E
AU - Michel G
AU - Locatelli F
AU - Bertaina A
AU - Veys P
AU - Dupont S
AU - Or R
AU - Gungor T
AU - Aleinikova O
AU - Sufliarska S
AU - Sundin M
AU - Rascon J
AU - Kaare A
AU - Nemet D
AU - Fagioli F
AU - Klingebiel TE
AU - Styczynski J
AU - Bierings M
AU - Nagy K
AU - Abecasis M
AU - Afanasyev B
AU - Ansari M
AU - Vettenranta K
AU - Alseraihy A
AU - Chybicka A
AU - Robinson S
AU - Bertrand Y
AU - Kupesiz A
AU - Ghavamzadeh A
AU - Campos A
AU - Pichler H
AU - Dalissier A
AU - Labopin M
AU - Corbacioglu S
AU - Balduzzi A
AU - Galimard JE
AU - Bader P
TI - Correction: Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/S41409-020-0854-0)
JO - Bone Marrow Transplantation
VL - 56
IS - 10
SP - 2615
EP -
PY - 2021
ER -

Science Communicator Platform

Authors

Abstract